Deepak Bhatt/mountsinai.org
Apr 2, 2025, 09:54
ACC 2025 Clinical Trials to Watch with Deepak Bhatt – Mount Sinai Department of Medicine
Mount Sinai Department of Medicine shared a post on LinkedIn:
“Deepak L. Bhatt previews 3 late-breaking clinical trials at ACC 2025, including a study on a novel reversal agent for Antiplatelet Therapy.
The trial demonstrated rapid and sustained efficacy, restoring normal blood clotting within minutes – a potential breakthrough for patients requiring urgent surgery or experiencing major bleeding.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 21:29
Aug 8, 2025, 21:08
Aug 8, 2025, 20:54
Aug 8, 2025, 20:18
Aug 8, 2025, 20:03
Aug 8, 2025, 19:51
Aug 8, 2025, 19:34